• Appointed Dr. David Kideckel as CFO effective Sept. 1, 2026.
• Kideckel was a managing director leading life sciences at a private investment bank, covering institutional equity research.
• Earlier roles included leadership positions at Johnson & Johnson and Alexion Pharmaceuticals, now part of AstraZeneca.
• Outgoing CFO Mirza Rahimani will become vice president of finance effective Sept. 1, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lobe Sciences Ltd. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202608280800ACCESSWRNAPR_____1213825) on August 28, 2026, and is solely responsible for the information contained therein.